Icon Advisers’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-33,600
Closed -$934K 283
2019
Q4
$934K Hold
33,600
0.13% 194
2019
Q3
$760K Hold
33,600
0.11% 216
2019
Q2
$848K Hold
33,600
0.08% 219
2019
Q1
$913K Hold
33,600
0.09% 204
2018
Q4
$1.11M Hold
33,600
0.12% 169
2018
Q3
$1.57M Buy
+33,600
New +$1.54M 0.13% 159
2017
Q3
Sell
-7,700
Closed -$465K 405
2017
Q2
$465K Buy
+7,700
New +$456K 0.03% 341
2016
Q4
Sell
-32,000
Closed -$2.12M 434
2016
Q3
$2.12M Sell
32,000
-11,800
-27% -$807K 0.14% 197
2016
Q2
$3.17M Buy
+43,800
New +$3.01M 0.22% 151
2014
Q4
Sell
-29,000
Closed -$1.59M 335
2014
Q3
$1.59M Buy
+29,000
New +$1.65M 0.09% 167
2013
Q3
Sell
-160
Closed -$7K 345
2013
Q2
$7K Buy
+160
New +$7.16K ﹤0.01% 323

Other funds holding MD

Icon Advisers's MD Position: Q1 2020 in Review

Icon Advisers sold out of Pediatrix Medical (MD) in Q1 2020, closing a stake of 33,600 shares — an estimated $934K sold.

Icon Advisers first reported a position in MD in Q2 2013 and held it in 11 quarters. The position peaked at $3.17M in Q2 2016. 221 funds tracked by Wall St. Rank hold MD as of Q1 2020.

  • Icon Advisers reported no remaining Pediatrix Medical position as of Q1 2020 after selling out during the quarter.
  • Icon Advisers sold 33,600 Pediatrix Medical shares in Q1 2020, an estimated $934K.
  • Icon Advisers first reported a position in Pediatrix Medical in Q2 2013 and held it in 11 quarters.
  • Icon Advisers's Pediatrix Medical position peaked at $3.17M in Q2 2016.
  • 221 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2020.

Based on Icon Advisers's 13F filing for Q1 2020, filed 1 May 2020.